Rigetti Q2: Revenue Surges, But Losses Deepen as Commercialization Distant

What happened

Rigetti’s Q2 revenue jumped 185.3% year-over-year to $5.1 million, beating estimates and highlighting early research-scale demand. However, operating losses widened to $28.1 million, missing earnings expectations as R&D and SG&A costs rose, underscoring that the business remains far from breakeven. The company’s $541.3 million cash position provides ample runway, but commercialization is still driven by lumpy development contracts rather than recurring usage. This mixed quarter neither derails nor accelerates the investment thesis, which hinges on the conversion of CHIPS policy support and technical milestones like C-DAC deployment and 108-qubit fidelity improvements. The stock’s $5.5 billion market cap continues to price in execution that has not yet materialized, keeping risk-reward balanced at current levels.

Implication

The Q2 revenue beat confirms that institutional demand for quantum systems exists, yet the widening loss and high cost base show the business lacks operating leverage at this scale. While the cash cushion eliminates near-term liquidity worries, the key CHIPS funding remains only a letter of intent with dilutive terms, and customer concentration remains extreme with one client representing 64% of quarterly revenue. The stock’s recent price near $16.50 sits inside the WAIT range, offering no margin of safety until definitive awards and commercialization evidence accrue. Investors should watch for progress on paid cloud usage and C-DAC deployment in H2 2026, as these are the next catalysts that could shift the risk-reward profile. Until then, the thesis is unchanged: Rigetti is a speculative bet on policy and technical milestones, not a de-risked growth story.

Thesis delta

The Q2 results are a mixed bag that reinforce the WAIT rating: top-line growth is encouraging but insufficient to alter the heavy-loss profile. None of the four critical milestones—definitive CHIPS award, C-DAC deployment, PSC build-out, or fidelity improvement—has been materially advanced by this release. The thesis remains equally dependent on these events, with no shift in probability or timing.